Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Denmark / NCT04048993
Recruiting Observational

Registry-based Biobank Development and Integrative Physiological Analysis

NCT04048993 · tracked via the Priya Life Science Denmark tracker
Sponsor
University of Copenhagen
Phase
Observational
Started
2019-09-01
Last updated
2025-02-10

Condition(s) studied

Integrative Human Physiology

Investigational drug(s) / intervention(s)

Biobank development and integrative physiological analysis

Biobank development and integrative physiological analysis: Collection of biological samples (blood, urine, interstitial fluid, adipose tissue and muscle) from subjects enrolled in the Section registry, using multivariate and data-mining approaches that includes also clinical and demographic parameters.

Study summary

The purpose is to develop a registry-based biobank for integrative physiological analysis based on biological samples (blood, urine, interstitial fluid and muscle) from subjects enrolled in the Section registry, using multivariate and data-mining approaches that includes also clinical and demographic parameters

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * able to perform fatiguing exercise Exclusion Criteria: * severe mental or physical handicap * chronic disease deemed by the M.D. to preclude inclusion * use of prescription medicine deemed by the M.D. to preclude inclusion

Primary outcome measure(s)

  • Biobank creation — through study completion, an average of 5 years
    Collection of biological samples from subjects included in the Section Registry

Trial sites (1)

FacilityCityRegionStatus
University of Copenhagen Copenhagen Denmark Recruiting

More University of Copenhagen trials in Denmark

Cancer-associated Muscle Mass - Molecular Factors and Exercise Mechanisms Recruiting
Ayurvedic Diet in Myxedema Recruiting
Does Paracetamol Influence the Release of Gut Hormones, Glucose Absorption and Glycemia? Recruiting
GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension Enrolling by invitation
The Effect of Fasting on Peak Fat Oxidation, Mitochondrial Coupling and Extracellular Matrix Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04048993 on ClinicalTrials.gov ↗ ← All trials in Denmark